Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1972 Feb;48(2):281–288.

Activation of factors XII and XI in thrombogenesis.

H L Nossel
PMCID: PMC1806802  PMID: 4257979

Full text

PDF
281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abildgaard C. F., Simone J. V., Schulman I. Factor-8 (antihaemophilic factor) activity in sickle-cell anaemia. Br J Haematol. 1967 Jan;13(1):19–27. doi: 10.1111/j.1365-2141.1967.tb08691.x. [DOI] [PubMed] [Google Scholar]
  2. BOTTI R. E., RATNOFF O. D. STUDIES ON THE PATHOGENESIS OF THROMBOSIS: AN EXPERIMENTAL "HYPERCOAGULABLE" STATE INDUCED BY THE INTRAVENOUS INJECTION OF ELLAGIC ACID. J Lab Clin Med. 1964 Sep;64:385–398. [PubMed] [Google Scholar]
  3. Baumann R., Straub P. W. Congenital deficiency of Hageman factor (clotting factor XII). Report on the first two families found in Switzerland. Helv Med Acta. 1968 Nov;34(4):313–326. [PubMed] [Google Scholar]
  4. CONNOR W. E., HOAK J. C., WARNER E. D. Massive thrombosis produced by fatty acid infusion. J Clin Invest. 1963 Jun;42:860–866. doi: 10.1172/JCI104778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Connor W. E., Hoak J. C., Warner E. D. The effects of fatty acids on blood coagulation and thrombosis. Thromb Diath Haemorrh Suppl. 1965;17:89–102. [PubMed] [Google Scholar]
  6. Connor W. E., Hoak J. C., Warner E. D. The effects of fatty acids on blood coagulation and thrombosis. Thromb Diath Haemorrh Suppl. 1965;17:89–102. [PubMed] [Google Scholar]
  7. DOLE V. P., JAMES A. T., WEBB J. P., RIZACK M. A., STURMAN M. F. The fatty acid patterns of plasma lipids during alimentary lipemia. J Clin Invest. 1959 Sep;38:1544–1554. doi: 10.1172/JCI103933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GORDON R. S., Jr, CHERKES A. Unesterified fatty acid in human blood plasma. J Clin Invest. 1956 Feb;35(2):206–212. doi: 10.1172/JCI103265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Girolami A., Agostino D., Cliffton E. E. The effect of ellagic acid on coagulation in vivo. Blood. 1966 Jan;27(1):93–102. [PubMed] [Google Scholar]
  10. Girolami A., Cliffton E. E. Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):165–175. [PubMed] [Google Scholar]
  11. Girolami A., Scarpa R., Solimbergo B. Tromboflebiti migranti ed ipercoagulabilita ematica da probabile attivazione del sistema fattore Hageman-PTA. (Caso clinico) Cardiol Prat. 1968 Feb;19(1):17–23. [PubMed] [Google Scholar]
  12. Glueck H. I., Roehill W., Jr Myocardial infarction in a patient with a hageman (factor XII) defect. Ann Intern Med. 1966 Feb;64(2):390–396. doi: 10.7326/0003-4819-64-2-390. [DOI] [PubMed] [Google Scholar]
  13. HASLAM R. J. ROLE OF ADENOSINE DIPHOSPHATE IN THE AGGREGATION OF HUMAN BLOOD-PLATELETS BY THROMBIN AND BY FATTY ACIDS. Nature. 1964 May 23;202:765–768. doi: 10.1038/202765a0. [DOI] [PubMed] [Google Scholar]
  14. HENDERSON E. S., RAPAPORT S. L. The thrombotic activity of activation product. J Clin Invest. 1962 Feb;41:235–244. doi: 10.1172/JCI104475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hoak J. C., Swanson L. W., Warner E. D., Connor W. E. Myocardial infarction associated with severe factor-XII deficiency. Lancet. 1966 Oct 22;2(7469):884–886. doi: 10.1016/s0140-6736(66)91981-7. [DOI] [PubMed] [Google Scholar]
  16. Lerner R. G., Rapaport S. I., Meltzer J. Thrombotic thrombocytopenic purpura. Serial clotting studies, relation to the generalized Shwartzman reaction, and remission after adrenal steroid and dextran therapy. Ann Intern Med. 1967 Jun;66(6):1180–1190. doi: 10.7326/0003-4819-66-6-1180. [DOI] [PubMed] [Google Scholar]
  17. Lipiński B., Worowski K., Jeljaszewicz J., Niewiarowski S., Rejniak L. Participation of soluble fibrin monomer complexes and platelet factor 4 in the generalized Shwartzman reaction. Thromb Diath Haemorrh. 1968 Nov 15;20(1):285–295. [PubMed] [Google Scholar]
  18. McKay D. G., Müller-Berghaus G., Cruse V. Activation of Hageman factor by ellagic acid and the generalized Shwartzman reaction. Am J Pathol. 1969 Mar;54(3):393–420. [PMC free article] [PubMed] [Google Scholar]
  19. Moskowitz R. W., Schwartz H. J., Michel B., Ratnoff O. D., Astrup T. Generation of kinin-like agents by chondroitin sulfate, heparin, chitin sulfate, and human articular cartilage: possible pathophysiologic implications. J Lab Clin Med. 1970 Nov;76(5):790–798. [PubMed] [Google Scholar]
  20. Müller-Berghaus G., Lasch H. G. Consumption of Hageman factor activity in the generalized Shwartzman reaction induced by liquoid. Its prevention by inhibition of Hageman factor activation. Thromb Diath Haemorrh. 1970 May 31;23(2):386–404. [PubMed] [Google Scholar]
  21. Niewiarowski S., Stuart R. K., Thomas D. P. Activation of intravascular coagulation by collagen. Proc Soc Exp Biol Med. 1966 Oct;123(1):196–200. doi: 10.3181/00379727-123-31440. [DOI] [PubMed] [Google Scholar]
  22. Nossel H. L., Niemetz J., Waxman S. A., Spector S. L. Defibrination syndrome in a patient with chronic thrombocytopenic purpura. Am J Med. 1969 Apr;46(4):591–598. doi: 10.1016/0002-9343(69)90077-1. [DOI] [PubMed] [Google Scholar]
  23. Nossel H. L., Wilner G. D., LeRoy E. C. Importances of polar groups for initiating blood coagulation and aggregating platelets. Nature. 1969 Jan 4;221(5175):75–76. doi: 10.1038/221075a0. [DOI] [PubMed] [Google Scholar]
  24. Prentice C. R., McNicol G. P., Douglas A. S. Effect of normal and atheromatous aortic tissue on platelet aggregation in vitro. J Clin Pathol. 1966 Jul;19(4):343–347. doi: 10.1136/jcp.19.4.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. RAPAPORT S. I., TATTER D., COEUR-BARRON N., HJORT P. F. PSEUDOMONAS SEPTICEMIA WITH INTRAVASCULAR CLOTTING LEADING TO THE GENERALIZED SHWARTZMAN REACTION. N Engl J Med. 1964 Jul 9;271:80–84. doi: 10.1056/NEJM196407092710206. [DOI] [PubMed] [Google Scholar]
  26. THOMAS D. P., WESSLER S., REIMER S. M. The relation of factors XII, XI, and IX to hypercoagulable states. Thromb Diath Haemorrh. 1963 Apr 15;9:90–101. [PubMed] [Google Scholar]
  27. TOMPKINS M. J., DAYTON S. RELATIONSHIP OF WHOLE BLOOD CLOTTING TIME TO PHYSIOLOGICAL VARIATIONS IN CIRCULATING SATURATED FREE FATTY ACIDS. Proc Soc Exp Biol Med. 1965 Jun;119:588–590. doi: 10.3181/00379727-119-30245. [DOI] [PubMed] [Google Scholar]
  28. WESSLER S., REIMER S. M. The role of human coagulation factors in serum-induced thrombosis. J Clin Invest. 1960 Feb;39:262–265. doi: 10.1172/JCI104036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. WESSLER S. Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis. J Clin Invest. 1955 Apr;34(4):647–651. doi: 10.1172/JCI103114. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES